Purchase Order N3239817P0255
Award Date 9/6/17
Potential Completion Date 9/22/17
Potential Value $96K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $89,232.71, was issued by the U.S. Navy Bureau of Medicine and Surgery (BUMED) to Illumina, Inc. Illumina, a manufacturer of genomic sequencing instruments and reagents, is providing health check services for BUMED's MiSeq and NextSeq 500 sequencing systems under this firm fixed price purchase order. The award is not associated with a larger contract vehicle and does not have a set-aside designation. Illumina has previously supported genomic research and...
- This federal contract award was made by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $119,742.91 firm fixed price purchase order is for a MiSeq System, related reagents, and support services to be performed in San Diego, CA. The contract does not have a set-aside designation. The award was made on a sole source basis to Illumina, as the provider of the proprietary...
- This is a $80,778.39 firm fixed price purchase order contract awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of the Navy, to Illumina, Inc. for CAT# MS-102-3003 MISEQ sequencing systems and associated items. The contract has no set-aside designation. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has a history of providing various sequencing platforms and consumables to support genomics research and diagnostic...
- This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a for-profit manufacturer of genetic analysis instruments and reagents. The $249,894.20 contract is for the delivery of an Illumina MiSeq sequencing system, to be used at the agency's location in Rockville, Maryland. Illumina has provided similar sequencing systems and related supplies to support genomic research and diagnostics at various federal agencies, including...
- This is a firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of the Navy, to Illumina, Inc. for $97,678.20. The award provides Illumina's RNA sequencing products and reagents to support the Naval Health Research Center's (NHRC) laboratory work characterizing biological threats. The contract has a period of performance through December 1, 2021. This award is not associated with a set-aside program. Illumina has previously...
- This is a firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Illumina, Inc., a manufacturer of genomic sequencing instrumentation and reagents. The $153,192.00 contract is for the provision of a MiSeq Silver sequencing system and associated products to support the agency's nucleic acid sequencing needs, specifically to characterize biological threats at the Naval Medical Research Center's Biological Defense Research...
- This is a firm fixed-price purchase order contract awarded by the U.S. Department of the Navy's Bureau of Medicine and Surgery (BUMED) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis products. The contract, valued at $80,858.46, is for the delivery of various Illumina sequencing systems, reagents, and consumables to support nucleic acid sequencing needs at the Naval Medical Research Center's Biological Defense Research Directorate. This award is made under an...
- This is a firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract is for the first shipment of MiSeq reagents, with a ceiling value of $130,556.94 and a completion date of September 30, 2024. Illumina has previously received prime contracts and subcontracts from various civilian and defense agencies to provide sequencing instruments, reagents, and associated...
- This federal contract award is to Illumina, Inc., a for-profit manufacturer, for a MiSeq System (CAT# SY-410-1003) under a firm fixed price purchase order from the Department of the Navy Bureau of Medicine and Surgery. The $120,089.00 award supports the National Interest Action Code for Coronavirus COVID-19 and does not use a set-aside designation. Illumina has previously delivered a range of genetic sequencing systems, reagents, and services to various federal agencies like the NIH, CDC,...
- This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $116,503.92 contract is for the delivery of undisclosed sequencing products and services to support the agency's mission. Illumina has an Indefinite Delivery Contract worth up to $3.3 million with the Navy for providing reagents and controls for various Illumina sequencing platforms used by the Naval...